Literature DB >> 18075471

Further evidence for association of GRK3 to bipolar disorder suggests a second disease mutation.

Thomas B Barrett1, John E Emberton, Caroline M Nievergelt, Sherri G Liang, Richard L Hauger, Eleazar Eskin, Nicholas J Schork, John R Kelsoe.   

Abstract

OBJECTIVES: Two genome-wide linkage surveys suggest chromosome 22q12 may contain a susceptibility locus for bipolar disorder (BPD) in the immediate region of the gene G protein receptor kinase-3 (GRK3). We previously published evidence that a single nucleotide polymorphism (SNP) in the promoter region of GRK3, designated P5, was associated with BPD. This SNP, however, was too rare (allele frequency 0.007) to explain the evidence for linkage.
METHODS: To identify other SNPs or haplotypes associated with illness, we have now sequenced an additional 28-kb genomic segment of GRK3 and tested an additional 35 SNPs for association with BPD in 181 Caucasian nuclear families.
RESULTS: Transmission disequilibrium test analyses identified two closely related disease-associated haplotypes defined by four SNPs located upstream of the promoter region: transmission to nontransmission ratios=54:22 and 20:9, odds ratios=2.50 and 2.36, and P values=0.0009 and 0.05. The best P value remained significant after correction for multiple testing. These two haplotypes were found on an entirely different set of chromosomes from the previously identified SNP P5. They had a combined frequency of approximately 0.10 and, therefore, a much greater population attributable risk for disease than the previously identified P5 haplotype.
CONCLUSIONS: These data provide evidence that at least two distinct haplotypes, and possibly two or more different underlying mutations, in GRK3 might be associated with BPD. These new findings add support for the hypothesis that a dysregulation in GRK3 expression alters signaling desensitization and thereby predisposes to the development of BPD.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18075471     DOI: 10.1097/YPG.0b013e3282efeeb4

Source DB:  PubMed          Journal:  Psychiatr Genet        ISSN: 0955-8829            Impact factor:   2.458


  10 in total

1.  Analysis of 94 candidate genes and 12 endophenotypes for schizophrenia from the Consortium on the Genetics of Schizophrenia.

Authors:  Tiffany A Greenwood; Laura C Lazzeroni; Sarah S Murray; Kristin S Cadenhead; Monica E Calkins; Dorcas J Dobie; Michael F Green; Raquel E Gur; Ruben C Gur; Gary Hardiman; John R Kelsoe; Sherry Leonard; Gregory A Light; Keith H Nuechterlein; Ann Olincy; Allen D Radant; Nicholas J Schork; Larry J Seidman; Larry J Siever; Jeremy M Silverman; William S Stone; Neal R Swerdlow; Debby W Tsuang; Ming T Tsuang; Bruce I Turetsky; Robert Freedman; David L Braff
Journal:  Am J Psychiatry       Date:  2011-04-15       Impact factor: 18.112

Review 2.  G protein-coupled receptor kinases: more than just kinases and not only for GPCRs.

Authors:  Eugenia V Gurevich; John J G Tesmer; Arcady Mushegian; Vsevolod V Gurevich
Journal:  Pharmacol Ther       Date:  2011-08-26       Impact factor: 12.310

3.  Genes and gene networks implicated in aggression related behaviour.

Authors:  Karim Malki; Oliver Pain; Ebba Du Rietz; Maria Grazia Tosto; Jose Paya-Cano; Kenneth N Sandnabba; Sietse de Boer; Leonard C Schalkwyk; Frans Sluyter
Journal:  Neurogenetics       Date:  2014-08-22       Impact factor: 2.660

Review 4.  The evolving impact of g protein-coupled receptor kinases in cardiac health and disease.

Authors:  Priscila Y Sato; J Kurt Chuprun; Mathew Schwartz; Walter J Koch
Journal:  Physiol Rev       Date:  2015-04       Impact factor: 37.312

5.  Differential effects of inescapable stress on locus coeruleus GRK3, alpha2-adrenoceptor and CRF1 receptor levels in learned helpless and non-helpless rats: a potential link to stress resilience.

Authors:  Manish Taneja; Samina Salim; Kaustuv Saha; H Kevin Happe; Nidal Qutna; Frederick Petty; David B Bylund; Douglas C Eikenburg
Journal:  Behav Brain Res       Date:  2011-02-17       Impact factor: 3.332

6.  Behavioral and pharmacological assessment of a potential new mouse model for mania.

Authors:  Melissa-Ann L Scotti; Grace Lee; Sharon A Stevenson; Alexandra M Ostromecki; Tyler J Wied; Daniel J Kula; Griffin M Gessay; Stephen C Gammie
Journal:  Physiol Behav       Date:  2011-03-22

Review 7.  Copy variations in schizophrenia and bipolar disorder.

Authors:  H M Lachman
Journal:  Cytogenet Genome Res       Date:  2009-03-11       Impact factor: 1.636

8.  Allele specific analysis of the ADRBK2 gene in lymphoblastoid cells from bipolar disorder patients.

Authors:  Michael J McCarthy; Thomas B Barrett; Stephanie Nissen; John R Kelsoe; Eric E Turner
Journal:  J Psychiatr Res       Date:  2009-09-18       Impact factor: 4.791

9.  Decreased GRK3 but not GRK2 expression in frontal cortex from bipolar disorder patients.

Authors:  Jagadeesh S Rao; Stanley I Rapoport; Hyung-Wook Kim
Journal:  Int J Neuropsychopharmacol       Date:  2009-04-29       Impact factor: 5.176

Review 10.  Targeting G protein coupled receptor-related pathways as emerging molecular therapies.

Authors:  Abdelaziz Ghanemi
Journal:  Saudi Pharm J       Date:  2013-08-13       Impact factor: 4.330

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.